BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36997287)

  • 41. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.
    Fuller GN; Scheithauer BW
    Brain Pathol; 2007 Jul; 17(3):304-7. PubMed ID: 17598822
    [No Abstract]   [Full Text] [Related]  

  • 42. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The 2021 WHO classification of tumours of the central nervous system].
    Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
    Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central Nervous System Tumor Classification: An Update on the Integration of Tumor Genetics.
    McLendon RE; Yachnis AT; Miller CR; Ng HK
    Hematol Oncol Clin North Am; 2022 Feb; 36(1):1-21. PubMed ID: 34763992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
    Malzkorn B; Reifenberger G
    Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification.
    Bai Y; Kakudo K; Jung CK
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):696-715. PubMed ID: 33261309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Histologic classification of central nervous system tumors by the World Health Organization].
    Szymaś J
    Pol J Pathol; 1994; 45(2):81-91. PubMed ID: 8062070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.
    Bai J; Varghese J; Jain R
    Top Magn Reson Imaging; 2020 Apr; 29(2):71-82. PubMed ID: 32271284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
    Cole BL; Pierson CR
    Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
    Komori T
    Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.
    Whitfield BT; Huse JT
    Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in Central Nervous System Tumor Classification.
    Malta TM; Snyder J; Noushmehr H; Castro AV
    Adv Exp Med Biol; 2023; 1416():121-135. PubMed ID: 37432624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical molecular pathology and histopathology of embryonal tumors.
    Phillips J; Tihan T; Fuller G
    Surg Pathol Clin; 2015 Mar; 8(1):73-88. PubMed ID: 25783823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.
    Jung CK; Bychkov A; Kakudo K
    Endocrinol Metab (Seoul); 2022 Oct; 37(5):703-718. PubMed ID: 36193717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [World Health Organization Classification of Central Nervous System Tumours, 5
    Ichimura K
    No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
    Penas-Prado M
    Am Soc Clin Oncol Educ Book; 2017; 37():187-191. PubMed ID: 28561706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 2021 WHO classification of central nervous system tumors: what neurologists need to know.
    Jamshidi P; Brat DJ
    Curr Opin Neurol; 2022 Dec; 35(6):764-771. PubMed ID: 36226717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Major Features of the 2021 WHO Classification of CNS Tumors.
    Smith HL; Wadhwani N; Horbinski C
    Neurotherapeutics; 2022 Oct; 19(6):1691-1704. PubMed ID: 35578106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
    Juratli TA; Jungk C; Miller JJ
    J Neurooncol; 2023 May; 162(3):457-459. PubMed ID: 37212938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.